Search

everythinglearnresearchcommunity

for

Search:↓

Patient history is key in diagnosing hair loss types.

Smoking 20+ cigarettes daily increases the risk of severe hair loss in men.

Microneedling with minoxidil is most effective for reducing hair loss and increasing hair volume.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Allergic scalp reactions can cause temporary hair loss.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Minoxidil with PRP is the best treatment for hair loss.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

The research shows a potential way to regenerate hair using adult cells that have been grown and guided to produce new hair fibers.

The combination of oral finasteride and topical 5% minoxidil effectively treats androgenic alopecia, especially after 3 months.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Low-level laser therapy is about 80% effective in treating hair loss, with best results in males, those who use it for over a year, and those with scalp conditions like dandruff and rash.

Estrogen affects hair growth, and GPER-1 levels might help identify hair loss types.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Scalp melanoma is often diagnosed late in people with hair loss, leading to worse outcomes.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Widened sweat ducts are a very specific sign of scarring hair loss.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

The M-type is the most common form of male hair loss, and the BASP-classification is easy for different medical professionals to use.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.